623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2016.02.663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Inflammation in Cardiac Amyloidosis: Prognostic Marker or Therapeutic Target?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

MERTK Is a Potential Therapeutic Target in Malignant Melanoma

Cancer Discovery
Oncology
2013English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

peIF4E as an Independent Prognostic Factor and a Potential Therapeutic Target in Diffuse Infiltrating Astrocytomas

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy